Reporting Season: Healthcare update
It's been a tough start to the healthcare reporting season with some wild swings in share prices (Ansell, Cochlear and CSL). Ansell provided some disappointing guidance for FY16 and the outlook for CSL was a little softer than what we were expecting, however this was a result of reinvestment in their R&D pipeline. We continue to like CSL so we are using the recent share price weakness as a buying opportunity. Next week Sonic Healthcare, Healthscope and Ramsay Health Care are reporting. We'll be keeping a close eye on these stocks and we expect them to deliver in line with consensus guidance. Senior Analyst Scott Power discusses his recommendation for these companies, as well as Capitol Health, in his latest Healthcare Update:
Morgans is Australia's largest national full-service retail stockbroking and wealth management network with over 240,000 client accounts, 500 authorised representatives and 950 employees operating from offices in all states and territories.